COVID-19 Clinical Trials

RBHS COVID-19 Clinical Trials

RBHS is actively engaged in scientific discovery surrounding COVID-19. 

Below are RBHS COVID-19 clinical trials.

 

RBHS Active COVID-19 Clinical Trials

Study Title PI
A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19 Yonatan Greenstein
A randomized controlled trial to evaluate the outcomes with Aggrenox in patients with SARS-CoV-2 infection Amit Singla
A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older Shobha Swaminathan
C298-020; A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Safetyand Efficacy of DUR-928 in Subjects Infected with SARS-CoV-2 with Acute or Chronic Liver or Kidney Disease Nikolaos Pyrsopoulos
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Ruxolitinib in Participants With COVID-19–Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) Amee Patrawalla
A Phase 2 double-blind placebo-controlled study investigating the safety and efficacy of EDP1815 in the treatment of patients hospitalized with SARS-CoV-2 Infection Rey Panettieri
Keith Guevarra
Treatment of Patients Hospitalized for Covid-19 Infection and Pulmonary Distress with Zanubrutinib Tilly Varughese
A5395 A Randomized, Double Blind, Placebo Controlled Trial to Evaluate the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons with COVID-19 Michelle Dalla Piazza
Investigational Covid-19 Convalescent Plasma Infusion for severely or life-threateningly ill Covid-19 Patients Marc Klapholz
Emergency Use of COVID-19 Covalescent Plasma in a Patient with Coronavirus Disease (COVID-19) Marc Klapholz
Tilly Varughese
A Phase 2 double-blind placebo-controlled study investigating the safety and efficacy of EDP1815 in the treatment of patients hospitalized with SARS-CoV-2 Infection Rey Panettieri
Clinical Features of COVID-19 Disease in Critically Ill Patients in the US: A Multicenter Study Jared Radbel
Hemolung RAS Emergency Use Authorizations for COVID-19 Sabiha Hussain
Jared Radbel
A Randomized, Double-blind, Vehicle-Controlled, Multicenter, Parallel-Group Study of APL-9 in Mild to Moderate Acute Respiratory Distress Syndrome Due to COVID-19 Sabiha Hussain
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older Jeffrey Carson
Influenza and Other Emerging Respiratory Pathogens Surveillance Registry Lawrence Kleinman
Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Severe Influenza-Associated Illness and Understanding Coronavirus Disease 2019 (Overcoming COVID-19) in US Children Lawrence Kleinman
The Pediatric COVID-19 Experience in Central New Jersey Lawrence Kleinman
Seroprevalence of infection with SARS-CoV-2 Virus Marila Gennaro
Fecal Study on COVID-19 Patients Vinod Rustgi